Refractory Childhood Soft Tissue Sarcoma: Clinical Trials

1 trial for Refractory Childhood Soft Tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Refractory Childhood Soft Tissue Sarcoma: new trials by email Literature Review of Refractory Childhood Soft Tissue Sarcoma trials Research Report on Refractory Childhood Soft Tissue Sarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Bone Scan - Advanced Malignant Solid Neoplasm, Recurrent Childhood Ependymoma
Phase 2Active not recruitingNational Cancer Institute (NCI)202018-06-052026-10-16

Narrower conditions

Central Nervous System Neoplasms (1)  ·  Ependymoma (1)  ·  Familial ependymoma (1)  ·  Glioma (1)  ·  Hepatoblastoma (1)  ·  Histiocytosis, Langerhans-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Medulloblastoma (1)  ·  Neuroblastoma (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Rhabdoid Tumor (1)  ·  Wilms Tumor (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Histiocytosis (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)

Interventions

Biopsy (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nuclear Medicine Department, Hospital (1)  ·  Phantoms, Imaging (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  erdafitinib (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Puerto Rico (1)  ·  United States (1)

Top investigators

Alice Lee (1)

Results publications

PMID 31401903

NIH funding

U10CA180886 (1), UM1CA081457 (1)